Drug supply system

Abstract

The present invention assists registration work for registering a drug storage unit with respect to a drug. A drug supply system including a drug packaging device is provided with: a cartridge that accommodates a drug; and a display unit (293) that displays information relating to the drug and the cartridge. The display unit (293) displays a list of candidates for switching when the medicaments contained in the cartridge are switched. The list contains an amount of each medicament dispensed from the medicament packaging device during the subject period.

Description

Technical Field

[0001] This disclosure relates to a pharmaceutical supply system. Background Technology

[0002] In the pharmaceutical supply device described in Japanese Patent Application Publication No. 2004-203433 (Patent Document 1), a specific type of pharmaceutical agent is stored in a medicine box. The pharmaceutical agent specified based on prescription data is discharged from the medicine box containing that agent. Pharmaceutical agents not stored in the medicine box are supplied from a pharmaceutical feeder having multiple storage compartments.

[0003] Existing technical documents

[0004] Patent documents

[0005] Patent Document 1: Japanese Patent Application Publication No. 2004-203433 Summary of the Invention

[0006] The problem the invention aims to solve

[0007] The drug container is configured to hold different types of drugs with specific shapes and sizes. When a drug is no longer used or its size changes, the drug container holding that drug can be used for other drugs, thus making efficient use of the drug container. In this case, a method for switching the registration of the drug container for a particular drug is required.

[0008] This disclosure proposes a drug supply system that can assist in the registration operations of the drug storage department for drug registration.

[0009] Solution for solving the problem

[0010] According to this disclosure, a pharmaceutical supply system including a pharmaceutical packaging device is proposed. The pharmaceutical supply system includes: a pharmaceutical receiving section that receives pharmaceuticals; and a display section that displays information related to the pharmaceuticals and the pharmaceutical receiving section. When switching between pharmaceuticals received in the pharmaceutical receiving section, the display section displays a list of pharmaceuticals that are candidates for switching. The list includes the quantity of each pharmaceutical dispensed from the pharmaceutical packaging device during the target period.

[0011] The effects of the invention

[0012] According to the drug supply system disclosed herein, the registration process for drug containment departments that contain drugs can be easily carried out. Attached Figure Description

[0013] Figure 1 This is a schematic front view of a pharmaceutical packaging device.

[0014] Figure 2 This is a 3D view of the box.

[0015] Figure 3 This is a block diagram representing the electrical connection system of the drug supply system.

[0016] Figure 4 This is a diagram representing an example of a pharmaceutical preparation table.

[0017] Figure 5 This is a graph representing an example of the corresponding data.

[0018] Figure 6 This is a flowchart illustrating the process of switching the registration of a drug box.

[0019] Figure 7 This is an example of a screen showing the selection of medicines.

[0020] Figure 8 This is an example of a screen showing the switching process.

[0021] Figure 9 This is an image of the switch registration screen indicating the selected state of the box to be switched.

[0022] Figure 10 This is an example of a newly registered screen. Detailed Implementation

[0023] The embodiments will now be described based on the figures. In the following description, the same reference numerals will be used to label the same parts and components. Their names and functions are also the same. Therefore, detailed descriptions will not be repeated. Sometimes, structures are omitted or simplified in the figures for ease of explanation. It was planned from the outset that arbitrary structures could be extracted from the embodiments and combined arbitrarily.

[0024] <Pharmaceutical Packaging Equipment 200>

[0025] Figure 1 This is a schematic front view of the pharmaceutical packaging device 200. (Example) Figure 1 As shown, the pharmaceutical packaging apparatus 200 according to the embodiment includes a housing 210, a main pharmaceutical supply unit 220, an auxiliary pharmaceutical supply unit 270, and a packaging unit 280. The main pharmaceutical supply unit 220, the auxiliary pharmaceutical supply unit 270, and the packaging unit 280 are respectively housed in the housing 210.

[0026] The pharmaceutical packaging device 200 dispenses medications based on prescription slips. The prescription slips are given to patients by doctors and contain prescription information. This prescription information includes medication information, such as the drug name, dosage, usage, and amount. The medication dispensing device supplies the medication in individual doses. The packaging unit 280 packages the medication supplied from the medication dispensing device into individual doses.

[0027] The pharmaceutical supply device includes a housing 210, a main pharmaceutical supply unit 220, and an auxiliary pharmaceutical supply unit 270. The main pharmaceutical supply unit 220 and the auxiliary pharmaceutical supply unit 270 supply solid pharmaceuticals, respectively. Examples of solid pharmaceuticals include tablets, pills, and capsules.

[0028] The pharmaceutical supply device may also include a powder supply unit. The powder supply unit supplies powdered or granular pharmaceuticals. Examples of powdered or granular pharmaceuticals include powders and granules.

[0029] Multiple boxes 100 are installed in the main medicine supply unit 220. Each box 100 contains a pre-defined type of medicine. Box 100 corresponds to an example of a medicine storage unit that contains medicines. Each box 100 can supply the medicine contained in it one by one.

[0030] Multiple boxes 100 are arranged in a manner that combines vertical and horizontal orientations. Figure 1 In the example shown, 15 boxes 100 are arranged in 3 columns vertically and 5 columns horizontally in the main drug supply unit 220. The number of boxes 100 arranged in the main drug supply unit 220 may also be more than 15.

[0031] Various medicines within a certain size range are stored in each of the multiple boxes 100 at staggered times. That is, the medicines stored in each of the multiple boxes 100 can be appropriately varied among various medicines within a certain size range. By preparing approximately ten types of boxes 100 according to the size and shape of the medicines, it is possible to supply most types of medicines. In this way, each of the multiple boxes 100 can supply medicines within a certain size range.

[0032] In this embodiment, each of the plurality of boxes 100 is provided with an RFID (Radio Frequency Identification) tag 10, which serves as a non-volatile recording medium. The RFID tag 10 stores container identification information, etc., for identifying the box 100. The RFID tag 10 is, for example, attached to the front surface of the box 100. Since the medication contained in the box 100 is not identified as a single type, the name of the contained medication is not recorded on the box 100.

[0033] A plurality of box bases 250 are provided in the main drug supply section 220. Each box base 250 supports a box 100 in a detachable manner. The box base 250 corresponds to one example of a support portion that supports the box 100. Furthermore, the number of box bases 250 may not be the same as the number of boxes 100. For example, the number of boxes 100 may be greater than the number of box bases 250. In this case, the plurality of boxes 100 can be appropriately used interchangeably with the box bases 250.

[0034] The auxiliary medicine supply unit 270 supplies medicines for which there is no corresponding box 100. The auxiliary medicine supply unit 270 has multiple containment compartments capable of containing medicines in dosage units. The auxiliary medicine supply unit 270 supplies medicines sequentially from the multiple containment compartments.

[0035] Multiple containment units are arranged in a matrix. The agent is directly or indirectly administered to each of the multiple containment units through manual distribution by an operator. Each containment unit has an openable and closable bottom. The agent is supplied from the containment unit by opening its bottom. Furthermore, the above-described structure of the auxiliary agent supply unit 270 is merely one example; as long as it has the same function, the auxiliary agent supply unit 270 may also have a different structure than described above.

[0036] The packaging section 280 is located below the medication supply device. The packaging section 280 feeds medication supplied in units from the medication supply device into a strip of packaging material, and simultaneously heat-welds and conveys it sequentially, thereby forming a series of packaging bags. Medications are contained in units within each of the series of packaging bags.

[0037] The control device 290 is electrically connected to the pharmaceutical packaging device 200. Details of the control device 290 will be described later.

[0038] <Box 100>

[0039] Figure 2 It's a 3D model of box 100. Figure 2 The middle figure shows a perspective view of the medicine containing chamber 110 in box 100 after a portion has been cut off and the cover has been removed. Box 100 includes the medicine containing chamber 110 and the rotor 120.

[0040] The medicine containing chamber 110 has a peripheral wall 111 and an outlet. The medicine is contained inside the peripheral wall 111 and discharged from the outlet. The inner surface of the peripheral wall 111 is cylindrical. The outlet is formed on the bottom surface of the box 100 and is adjacent to the inner surface of the peripheral wall 111 on the radially inner side.

[0041] A circular opening is provided on the bottom surface of the medicine containing chamber 110 at a position on the central axis of the peripheral wall 111. A drive shaft (not shown) connected to the rotor 120 is inserted through the opening. The drive shaft and the rotor 120 are coaxial and rotatably fixed to the inner side of the peripheral wall 111. That is, the drive shaft is rotatably fixed to the medicine containing chamber 110. The drive shaft is mounted on the rotor 120 in a manner that allows it to be axially attached and detached. The drive shaft drives the rotation of the rotor 120.

[0042] Rotor 120 is disposed inside the drug containment chamber 110 and rotates to transport the drug contained in the drug containment chamber 110 to the discharge port. Rotor 120 is disposed inside the peripheral wall 111 and on the bottom surface of the drug containment chamber 110. Rotor 120 is configured to perform both forward rotation (rotating in one direction in the circumferential direction of rotor 120) and reverse rotation (rotating in the other direction in the circumferential direction of rotor 120). However, rotor 120 does not necessarily need to be able to perform both forward and reverse rotation; it is sufficient that it can rotate in at least one direction in the circumferential direction of rotor 120.

[0043] The rotor 120 has an upwardly convex top surface 126 and a peripheral surface 121 adjacent to the top surface 126. A plurality of grooves 127 are radially arranged on the top surface 126. A cylindrical central protrusion 128 protrudes from the center of the top surface 126. A cover 160 is mounted on the upper end of the central protrusion 128. The cover 160, when the rotor 120 is mounted on the drive shaft, and the cover, when the drug containment chamber 110 is closed, face each other with a gap between them.

[0044] A plurality of first protrusions 122 and a plurality of second protrusions 123 are provided on the lower part of the circumferential surface 121, located at positions spaced apart from each other by a gap 125 in the circumferential direction of the rotor 120. Viewed radially from the rotor 120, each of the plurality of first protrusions 122 and the plurality of second protrusions 123 has a generally rectangular shape. The front ends of each of the plurality of first protrusions 122 and the plurality of second protrusions 123 in the radial direction of the rotor 120 face each other at a slight interval from the inner surface of the circumferential wall 111.

[0045] Each of the plurality of first protrusions 122 and the plurality of second protrusions 123 is configured to push the medicine contained in the gap 125 and deliver it to the discharge port when the rotor 120 rotates. Specifically, as the rotor 120 rotates, the medicine contained in the gap 125 is pushed by the first protrusions 122 or the second protrusions 123 and delivered along the circumference of the rotor 120, thus falling toward the discharge port.

[0046] At least two third protrusions 124 are also provided on the peripheral surface 121. In an embodiment, a third protrusion 124 is disposed above each of the second protrusions of the plurality of second protrusions 123. The radially front end of the rotor 120 of each of the at least two third protrusions 124 faces the inner surface of the peripheral wall 111 at a slight interval.

[0047] The substrate 141 is mounted to the hole in the peripheral wall 111. Multiple flexible members are joined to the arc-shaped substrate 141 at intervals along the arc, forming a partition 140. The partition 140 extends from the inner surface of the peripheral wall 111 toward a position in the peripheral surface 121 above the multiple first protrusions 122 and multiple second protrusions 123. The gap 125 communicating with the discharge port is covered by the partition 140, thereby preventing the medicine from entering from above. Thus, it is possible to prevent the unintended continuous discharge of multiple medicines from the discharge port, and to supply medicines one by one from the discharge port.

[0048] A passage is provided between the second protrusion 123 and the third protrusion 124 arranged in a vertical direction for the partition 140 to pass through when the rotor 120 rotates. The third protrusion 124 is configured to push the medicine located on the partition 140 and move it off the partition 140 when the rotor 120 rotates.

[0049] <Pharmacy Supply System>

[0050] Figure 3 This is a block diagram representing the electrical connection system of the pharmaceutical supply system. The pharmaceutical packaging device 200 is electrically connected to the control device 290 via a network. For example... Figure 3 As shown, multiple pharmaceutical packaging devices 200 can also be connected to the control device 290. The pharmaceutical supply system may also include a first pharmaceutical packaging device 200 (machine 1 201), a second pharmaceutical packaging device 200 (machine 202), and a third pharmaceutical packaging device 200 (machine 3 203).

[0051] The control device 290 includes a control unit 291, an operation unit 292, a display unit 293, and a storage unit 294.

[0052] The operation unit 292 is operated by the operator of the medicine packaging device 200. The operation unit 292 consists of input devices such as a keyboard, mouse, and touch panel. By operating the operation unit, the operator inputs the information required for dispensing medicine using the medicine packaging device 200 into the control device 290.

[0053] The information required for dispensing medication using the medication packaging device 200 includes prescription data based on the prescription slip and various setting information. This information can also be input to the control device 290 from the prescription input device 1, which is an external computer.

[0054] The display unit 293 is composed of a display device such as a liquid crystal monitor. The display unit 293 displays various information. The information displayed on the display unit 293 is, for example, information related to the medicine and the box 100.

[0055] Storage unit 294 stores programs for performing various operations of the pharmaceutical packaging device 200, and stores information required for dispensing pharmaceuticals using the pharmaceutical packaging device 200. Storage unit 294 is a hard disk drive or SSD (Solid State Drive) for storing various types of data.

[0056] The control unit 291 controls the operation of the pharmaceutical packaging device 200 based on the program stored in the storage unit 294. The control unit 291 may include a CPU (Central Processing Unit), RAM (Random Access Memory), ROM (Read Only Memory), and EEPROM (Electrically Erasable Programmable Read-Only Memory). The control unit 291 may also be an integrated circuit such as an ASIC (Application Specific Integrated Circuit) or a DSP (Digital Signal Processor).

[0057] like Figure 3 As shown, each of the plurality of cartridge bases 250 in the main drug supply unit 220 includes a drive unit 251 and a reading unit 252. The drive unit 251 drives the cartridge 100. The drive unit 251 includes an electric motor. When the cartridge 100 is mounted on the cartridge base 250, the drive unit 251 is connected to the rotor 120 of the cartridge 100. The drive unit 251 rotates the rotor 120 of the cartridge 100.

[0058] The reading unit 252 includes an antenna, etc. The reading unit 252 reads information stored in the RFID tag 10 of the box 100. The reading unit 252 reads container identification information from the RFID tag 10. The reading unit 252 reads information used to identify the box 100.

[0059] The pharmaceutical packaging device 200 includes a control unit 240. Information read by the reading unit 252 is input from the reading unit 252 to the control unit 240. The control unit 240 is configured to communicate with the control unit 291 of the control device 290.

[0060] <Pharmacy Main Table 300>

[0061] Figure 4 This is a diagram showing an example of a main medicine table 300. The main medicine table 300 is, for example, stored in the storage unit 294 of the control device 290. Figure 3 Users of the drug supply system operate the operation unit 292 of the control device 290 to input information, thereby creating or updating the drug master table 300.

[0062] In the main drug table 300, information related to each drug is registered. The main drug table 300 includes a drug identification information field 310, a drug name field 320, an adoption / discontinuation field 330, a first box identification information field 340, a first machine field 350, a second box identification information field 360, and a second machine field 370.

[0063] The drug identification information field 310 contains a code inherent to the drug. This code could be, for example, the YJ code. The drug name field 320 contains the name of the drug. The adopt / discontinue field 330 contains information about whether the drug is suitable for dispensing from the drug packaging device 200. There is an adopt flag associated with each drug. When a drug is added to the main drug table 300, the adopt flag is set to "on" to indicate adoptability in the adopt / discontinue field 330 of the main drug table 300. The adopt flag is set to "off" to indicate dispensability in the adopt / discontinue field 330 of the main drug table 300. Drugs that are dispensable in the adopt / discontinue field 330 will no longer be dispensed from the drug packaging device 200.

[0064] The identification information fields 340 and 360 of the first and second boxes contain identification information for the registered box 100 of the drug. The identification information for box 100 is a unique identification number specific to each box 100. The first three capital letters and two numbers in the identification information indicate the type of box 100. The last four digits (#) and three numbers in the identification number constitute the serial number of box 100. For boxes of the same type, the identification number is the same, but the serial number is different. For example... Figure 4 There is only one box 100 with a seven-digit identification number as shown.

[0065] The first machine unit 350 includes a pharmaceutical packaging device 200. Figure 3The information shown in Unit 1 (201), Unit 2 (202), and Unit 3 (203) pertains to the pharmaceutical packaging device 200 capable of housing the box 100 shown in the first box identification information field 340. The second unit field 370 contains information about the pharmaceutical packaging device 200 (…). Figure 3 Information on the pharmaceutical packaging device 200 that can install the box 100 shown in the second box identification information column 360 in units 1 (201, 202, and 3 (203)).

[0066] exist Figure 4 The table shows six drug information entries, 301 to 306, but the number of drug information entries contained in the main drug table 300 is arbitrary. Of course, the main drug table 300 can also contain more than seven drug information entries.

[0067] Pharmaceutical information 301-306 respectively contain information related to tablets A through F. A box 100 with identification number A23#001 is registered for tablet A. Tablet A is contained in box 100 with identification number A23#001. The following situation is shown: when dispensing tablet A using the pharmaceutical packaging device 200, tablet A is dispensed from box 100 with identification number A23#001 installed in the main pharmaceutical supply unit 220 and supplied to the packaging unit 280.

[0068] Box 100 with identification number B51#001 was registered for tablet B. Multiple boxes 100 were registered for tablet C, including box 100 with identification number A23#002 and box 100 with identification number A23#003. Box 100 with identification number A23#002 was registered as a box for containing tablet C. Box 100 with identification number A23#003 was also registered as a box for containing tablet C. Multiple boxes 100 can be registered for one type of medication.

[0069] Box 100 is not registered for D tablets, E tablets, and F tablets. Not all types of medications are registered with a box 100 for containing them. For example, medications used infrequently are sometimes not registered with a box 100 for containing them.

[0070] Regarding tablet D, it is set to "discontinued" in the "adopt / discontinue" field 330, therefore tablet D will not be dispensed from the pharmaceutical packaging device 200. Regarding tablets E and F, they are set to "adopted" in the "adopt / discontinue" field 330, therefore tablets E and F are sometimes dispensed from the pharmaceutical packaging device 200. Since there is no box 100 for holding tablet E, when using the pharmaceutical packaging device 200 to dispense tablet E, tablet E can be supplied to the packaging unit 280 using the auxiliary pharmaceutical supply unit 270. Similarly, tablet F can also be supplied using the auxiliary pharmaceutical supply unit 270.

[0071] <Corresponding data 400>

[0072] Figure 5 This diagram illustrates an example of corresponding data 400. For example, corresponding data 400 is stored in the storage unit 294 of the control device 290. Figure 3 A master table representing the correspondence between the medicine and box 100 is pre-created. This master table data is then imported into the control device 290 in CSV format. Figure 5 The corresponding data shown is 400.

[0073] The corresponding data 400 includes the drug name field 410, the pharmaceutical company name field 420, the drug identification information field 430, and the box type field 440.

[0074] The drug name field 410 contains the name of the drug. The pharmaceutical company name field 420 contains the name of the pharmaceutical company that manufactured the drug. The drug identification information field 430 contains a code unique to the drug. This code could be, for example, the YJ code. The box type field 440 contains an identification number consisting of uppercase letters and two numbers, indicating the type of box 100 designated as the box corresponding to the drug. The corresponding data 400 may also contain information such as the shape, diameter, and thickness of the drug.

[0075] exist Figure 5 The data shows six drug information entries, 401 to 406, but the number of drug information entries contained in the corresponding data 400 is arbitrary. Of course, the corresponding data 400 can also contain more than seven drug information entries.

[0076] Drug information 401-406 contains information related to tablets A through F, respectively. The type of box 100 corresponding to tablets A, C, and E is A23. The type of box 100 corresponding to tablets B and D is B51. Multiple drugs can be contained in boxes 100 of the same type. No box 100 is specified for tablet F; it is set as non-compliant in the box type field 440 of drug information 406. Not all types of drugs have a corresponding box 100. For drugs with special shapes and sizes, sometimes no corresponding box 100 is specified.

[0077] <Registration Switching for Box 100>

[0078] Figure 6 This is a flowchart illustrating the process of switching the registration of the medicine box 100. The control unit 291 of the control device 290 displays information on the display unit 293. The user of the medicine supply system observes the information displayed on the display unit 293 and operates the operation unit 292 to switch the registration of the medicine box 100. Switching the registration means registering to change the medicine contained in a specific box 100 from the currently contained medicine to another medicine.

[0079] When switching the medicine contained in the box 100, firstly, in step S1, the control unit 291 causes the display unit 293 to display the medicine selection screen 500.

[0080] Figure 7 This is an example of a drug selection screen 500. The drug selection screen 500 is used to switch the registration of a box 100 for a particular drug when storing another drug in a box 100 already registered for that drug. The source drug is the drug currently registered in box 100 for that drug. The target drug is the drug for which you want to newly register in box 100. The drug selection screen 500 is used to select both the source and target drugs for switching.

[0081] like Figure 7 As shown, the drug selection screen 500 includes a source extraction unit 510, a target extraction unit 520, an object display 530, a source selection list 540, a target selection list 550, and an operation bar 590.

[0082] The source extraction switching unit 510 includes a box type input unit 511, a drug name input unit 512, and a pharmaceutical company name input unit 513. The user can input an identification number indicating the type of box 100 in the box type input unit 511. The user can input the name of the drug in the drug name input unit 512. The user can input the name of the pharmaceutical company that manufactured the drug in the pharmaceutical company name input unit 513.

[0083] Users can extract drugs that can become switching source candidates by inputting information into one or more of the following: box type input section 511, drug name input section 512, and pharmaceutical company name input section 513. Drugs can be extracted using AND conditions by inputting information into the multiple input sections of the switching source extraction section 510. For example, by inputting the name of a drug into the drug name input section 512, drugs with that name can be extracted as switching source candidates. Alternatively, for example, by inputting an identification number into the box type input section 511, drugs corresponding to the type of box 100 represented by that identification number can be extracted as switching source candidates.

[0084] The target extraction unit 520 includes a box type input unit 521, a drug name input unit 522, and a pharmaceutical company name input unit 523. The user can input an identification number indicating the type of box 100 in the box type input unit 521. The user can input the name of the drug in the drug name input unit 522. The user can input the name of the pharmaceutical company that manufactured the drug in the pharmaceutical company name input unit 523.

[0085] Users can extract drugs that become switching target candidates by inputting information into one or more of the following: box type input unit 521, drug name input unit 522, and pharmaceutical company name input unit 523. Drugs are extracted using AND conditions by inputting information into multiple input units of the switching target extraction unit 520. For example, by inputting the name of a drug into the drug name input unit 522, drugs with that name can be extracted as switching target candidates. Alternatively, by inputting an identification number into the box type input unit 521, drugs corresponding to the type of box 100 represented by that identification number can be extracted as switching target candidates.

[0086] The target period display 530 shows the target period for counting the quantities of various medicines dispensed from the medicine packaging device 200. The user can change the first day of the target period by entering or selecting a date in the first day of the period designation section 531. The user can change the last day of the target period by entering or selecting a date in the last day of the period designation section 532. The user can arbitrarily change the target period by specifying the first and last days. The calendar can also be displayed by the user clicking the downward-pointing black triangle marker shown to the right of the first day of the period designation section 531 or the last day of the period designation section 532.

[0087] The initial value for the object period can be a period of one month prior to the current year, month, and day. The initial value for the period final day specification section 532 can be the current year, month, and day. The initial value for the period first day specification section 531 can be the date of the day following the date one month prior to the current year, month, and day.

[0088] The switching source list 540 is a list of drugs that can become switching source candidates. The display unit 293 displays the list of drugs that can become switching source candidates. The switching source list 540 only includes drugs that are registered in box 100 in the main drug table 300. The switching source list 540 does not include drugs that are not registered in box 100 in the main drug table 300. If no input is made in the input section of the switching source extraction unit 510, all drugs that are registered in box 100 in the main drug table 300 are displayed in the switching source list 540.

[0089] The source switching list 540 includes a selection bar 541, a drug name display bar 542, a dosage display bar 543, a box type display bar 544, and an adoption / discontinuation display bar 545.

[0090] The names of the drugs that are candidates for switching sources are displayed in the drug name display field 542. The quantity used display field 543 displays the quantity of each drug dispensed from the drug packaging device 200 during the target period. The box type display field 544 displays an identification number consisting of uppercase letters and two numbers, indicating the type of box 100 registered for the drug displayed in the drug name display field 542. The box type display field 544 displays the types of boxes 100 capable of containing the drugs displayed in the drug name display field 542. The use / discontinue display field 545 displays information on whether the drug is being used as a target dispensed from the drug packaging device 200.

[0091] In selection bar 541, checkboxes are displayed for each medicine. The user interacts with selection bar 541 corresponding to one of the medicines displayed in the switching source list 540 to mark a checkbox, thereby selecting that medicine as a switching source. Only one medicine can be selected as a switching source. Multiple medicines cannot be selected as switching source medicines. It is possible to mark a checkbox in one of the multiple checkboxes in selection bar 541, but not in more than two checkboxes.

[0092] exist Figure 7 In the example shown, in the switching source list 540, drugs that can become switching source candidates are extracted based on their names. Specifically, tablet C is input into the drug name input section 512 of the switching source extraction section 510, and tablet C is extracted as a drug that can become a switching source candidate. Therefore, tablet C is displayed in the switching source list 540. Observing the box type display column 544, it can be seen that the box 100 registered for tablet C is the box of type A23.

[0093] Switch source list 540 only includes Figure 4 The medicine in box 100 is registered in the main medicine table 300 shown. The switching source list 540 includes medicines not included in the main medicine table 300 that are not registered in box 100. Figure 4 In the example shown, the switching source list 540 contains tablets A, B, and C, but does not contain tablets D, E, and F.

[0094] In the main drug table 300, a drug registered in box 100 means that there exists a box 100 that contains the drug. For drugs registered in box 100, the box 100 exists regardless of whether it is installed in the drug packaging device 200 or not.

[0095] Regarding the medicine in unregistered box 100, since there is no box 100 containing the medicine, it is not displayed in the switching source list 540. It is impossible for a box 100 containing the medicine to be installed in the medicine packaging device 200.

[0096] The switching target list 550 is a list of drugs that can become switching target candidates. The display unit 293 displays the list of drugs that can become switching target candidates. The switching target list 550 includes both drugs that are registered in box 100 in the main drug list 300 and drugs that are not registered in box 100 in the main drug list 300. If no input is made in the input unit of the switching target extraction unit 520, the switching target list 550 displays all drugs included in the main drug list 300 (all drugs that are registered in box 100 in the main drug list 300 and all drugs that are not registered in box 100 in the main drug list 300).

[0097] The target switching list 550 includes a selection bar 551, a drug name display bar 552, a dosage display bar 553, a box type display bar 554, a registration display bar 555, and an adoption / discontinuation display bar 556. The target switching list 550 may also include information such as the shape, diameter, and thickness of the drug.

[0098] The name of the drug that has become a candidate for switching target is displayed in the drug name display column 552. The quantity of drug used is displayed in the quantity display column 553 for each drug, showing the quantity of drug dispensed from the drug packaging device 200 during the target period.

[0099] The box type display field 554 displays an identification number consisting of uppercase English letters and two numbers, which indicates the type of box 100 corresponding to the drug displayed in the drug name display field 552. The box type display field 554 displays the types of box 100 that can contain the drug displayed in the drug name display field 552.

[0100] If a box 100 for a drug is registered in the main drug list 300, the identification number indicating the type of the registered box 100 will be displayed in the box type display column 554. If a box 100 for a drug is not registered in the main drug list 300, the box type display column 554 will display... Figure 5 The corresponding data 400 shows the identification number of the type of box 100 that is designated as the box corresponding to the medicine. If the box 100 registered in the main medicine table 300 is different from the box 100 specified in the corresponding data 400, the box 100 registered in the main medicine table 300 will be displayed first in the box type display column 554.

[0101] The registration display field 555 shows whether the medicine box 100 has been registered in the main medicine table 300. For medicines whose boxes 100 are registered in the main medicine table 300, the registration display field 555 displays "registered". The switching target list 550 includes medicines whose boxes 100 are not registered in the main medicine table 300; for medicines whose boxes 100 are not registered in the main medicine table 300, the registration display field 555 displays "not registered". The adoption / discontinuation display field 556 displays information about whether the medicine is being adopted as a dispensing agent from the medicine packaging device 200.

[0102] In selection bar 551, checkboxes are displayed for each type of medicine. The user interacts with selection bar 551 corresponding to a medicine displayed in the switch target list 550, marking the checkbox with a checkmark, thereby selecting that medicine as the switch target. Only one medicine can be selected as the switch target. Multiple medicines cannot be selected as the switch target. It is possible to mark one checkbox in multiple checkboxes in selection bar 551 with a checkmark, but not more than two checkboxes.

[0103] exist Figure 7 In the example shown, the switching target list 550 extracts drugs that can become switching target candidates based on the type of box 100. Specifically, since A23 is input into the box type input section 521 of the switching target extraction section 520, the switching target list 550 displays drugs that can be contained in box 100 with identification number A23.

[0104] Alternatively, at the selected time point for switching the source drug, the drug that can become a switching target candidate can be extracted based on the type of the box 100 corresponding to the switching source drug. In this case, the identification number indicating the type of box 100 corresponding to the switching source drug can be automatically displayed in the box type input unit 521 of the switching target extraction unit 520.

[0105] Alternatively, at the selected time point for switching the target drug, drugs that can become switching source candidates can be extracted based on the type of the box 100 corresponding to the target drug. In this case, the identification number indicating the type of box 100 corresponding to the target drug can be automatically displayed in the box type input unit 511 of the switching source extraction unit 510.

[0106] Information regarding the multiple medications displayed in the switching source list 540 and the switching target list 550 can be sorted in ascending or descending order by operating the header. For example, by clicking the inside of the rectangle surrounding the text "Usage" in the header of the usage display columns 543 and 553, the medications are sorted in ascending order by the quantity dispensed from the medication packaging device 200 during the target period; by clicking again, the medications are sorted in descending order by quantity. Similarly, by clicking the inside of the rectangle surrounding the text "Register" in the header of the registration display column 555, medications with registered boxes 100 are displayed above; by clicking again, medications without registered boxes 100 are displayed above.

[0107] Display unit 293 simultaneously displays both the switching source list 540 and the switching target list 550. Display unit 293 displays information related to both the switching source drug and the switching target drug. The switching source list 540 and the switching target list 550 are arranged vertically on display unit 293.

[0108] The operation bar 590 is displayed at the bottom of the drug selection screen 500. The operation bar 590 can be operated by clicking the mouse or clicking the screen while the mouse pointer is positioned inside the multiple rectangles included in the operation bar 590. The operation bar 590 includes a CSV output operation unit 591, a close operation unit 592, a new registration operation unit 593, and a toggle operation unit 594.

[0109] By operating the CSV output operation unit 591, the contents displayed in the switching source list 540 and the switching target list 550 are output in CSV format. By operating the close operation unit 592, the drug selection screen 500 is closed, and the screen displayed on the display unit 293 changes to another screen. By operating the new registration operation unit 593, the screen displayed on the display unit 293 changes from the drug selection screen 500 to the new registration screen 700. Figure 10 By operating the switching operation unit 594, the screen displayed on the display unit 293 changes from the drug selection screen 500 to the switching registration screen 600. Figure 8 ).

[0110] exist Figure 7In the example shown, the user inputs "C tablet" in the drug name input section 512 of the switching source extraction unit 510, thereby displaying "C tablet" in the switching source list 540. The box type display field 544 displays an identification number A23 indicating the type of box 100 registered for "C tablet". The user inputs this identification number A23 in the box type input section 521 of the switching target extraction unit 520, thereby displaying drugs that can be contained in the box 100 with identification number A23 in the switching target list 550. In this case, the box 100 serving as the switching source and the box 100 serving as the switching target are of the same box type, therefore, switching is possible.

[0111] On the other hand, if the box 100 registered for the switching source drug is a different type of box 100 from the box 100 registered for the drug to be selected as the switching target, then it is set as non-switchable. In this case, an alarm is issued at the time when the switching operation unit 594 is operated. For example, a message indicating that the box types are different pops up on the drug selection screen 500. In this case, even if the switching operation unit 594 is operated, the screen displayed on the display unit 293 will not switch to the switching registration screen 600.

[0112] Return to Figure 6 In step S2, the control unit 291 determines whether a decision operation has been performed. Here, a decision operation refers to operating the switching operation unit 594 while selecting a drug in both the switching source list 540 and the switching target list 550 in the drug selection screen 500. If it is determined that no decision operation has been performed ("No" in step S2), the determination in step S2 is repeated. Processing is paused until a decision operation is performed.

[0113] When it is determined that a decision operation has been performed ("Yes" in step S2), in step S3, the control unit 291 causes the display unit 293 to display the switching registration screen 600. Figure 8 This is an example of a screen displaying the registration process (600). For example... Figure 8 As shown, the switching registration screen 600 includes a switching source display unit 610, a switching target display unit 650, and an operation bar 690. The display unit 293 simultaneously displays the switching source display unit 610 related to the switching source drug and the switching target display unit 650 related to the switching target drug. The switching source display unit 610 and the switching target display unit 650 are arranged horizontally in the display unit 293.

[0114] The switching source display unit 610 includes a drug name 620 and a box information list 630. The drug name 620 displays the name of the drug selected as the switching source. The box information list 630 displays information related to the box 100 registered for the drug shown in the drug name 620. The switching source display unit 610 displays information about the switching source drug and information about the box 100 registered for that drug.

[0115] The box information list 630 includes a selection bar 631, a box identification information display bar 632, a selection bar 633 for machine 1, a selection bar 634 for machine 2, and a selection bar 635 for machine 3.

[0116] The box identification information display field 632 displays the identification information of the box 100 registered for the drug shown in the drug name 620. The box identification information display field 632 displays a seven-digit identification number containing an identification number indicating the type of box 100 and a serial number of box 100. In the case of multiple boxes 100 containing switching source drugs, the box identification information display field 632 displays the identification information of each of these multiple boxes 100.

[0117] In the selection bar 633 of machine 1, selection bar 634 of machine 2, and selection bar 635 of machine 3, a check mark is shown for the pharmaceutical packaging device 200 that is specified to be able to install the box 100 shown in the box identification information display bar 632.

[0118] Refer to together Figure 4 In the main drug list 300, for box 100 with identification number A23#002 and box 100 with identification number A23#003 registered for C tablets, it is stipulated that any box 100 can be installed in machine 201 ( ). Figure 3 Therefore, in Figure 8 In the switching source display unit 610 shown, the identification number A23#002 is displayed in the box identification information display column 632 in the first row of the box information list 630, and a check mark is marked in the No. 1 selection column 633. Additionally, in the switching source display unit 610, the identification number A23#003 is displayed in the box identification information display column 632 in the second row of the box information list 630, and a check mark is marked in the No. 1 selection column 633.

[0119] In selection bar 631, checkboxes are displayed for each box 100. The user operates selection bar 631 corresponding to at least one box 100 displayed in box information list 630 to mark a checkbox as a selection, thereby selecting that box 100 as the switching source. When multiple boxes 100 are displayed in box information list 630, one or more boxes 100 can be selected as the switching target.

[0120] The target switching display unit 650 includes a drug name 660 and a box information list 670. The drug name 660 displays the name of the drug selected as the switching target. The box information list 670 displays information related to the box 100 registered for the drug shown in drug name 660. The target switching display unit 650 displays information about the target drug and information about the box 100 registered for that drug.

[0121] The box information list 670 includes a box identification information display bar 672, a selection bar for machine 1 673, a selection bar for machine 2 674, and a selection bar for machine 3 675.

[0122] The box identification information display column 672 displays the identification information of box 100 registered for the drug shown in drug name 660. The box identification information display column 662 displays a seven-digit identification number containing an identification number indicating the type of box 100 and a serial number of box 100.

[0123] In the selection bar 673 of machine 1, selection bar 674 of machine 2, and selection bar 675 of machine 3, a check mark is displayed for the pharmaceutical packaging device 200 that is specified to be able to install the box 100 shown in the box identification information display bar 672.

[0124] Refer to together Figure 4 In the main pharmaceutical table 300, box 100 is not registered for E tablets. Therefore, in Figure 8 The switching target display unit 650 does not display any information about box 100. If the drug selected as the switching target is a drug for which box 100 is registered in the drug master table 300, then the information of the box 100 registered for that drug is displayed in the box information list 670.

[0125] The operation bar 690 is displayed at the bottom of the registration screen 600. The operation bar 690 can be operated by clicking the mouse or clicking the screen while the mouse pointer is positioned inside the multiple rectangles included in the operation bar 690. The operation bar 690 includes a close operation unit 692 and an execute operation unit 694.

[0126] By operating the shutdown operation unit 692, the registration switch screen 600 is closed, and the screen displayed on the display unit 293 changes to another screen. By operating the execution operation unit 694, the registration of box 100 is switched from switching source drug to switching target drug. By operating the execution operation unit 694, box 100 that was registered for the switching source drug before the operation of the execution operation unit 694 is switched to box 100 registered for the switching target drug.

[0127] Return to Figure 6In step S4, the control unit 291 determines whether an execution operation has been performed. Here, execution operation refers to operating the execution operation unit 694 while one or more boxes 100 are selected in the box information list 630 of the switching source display unit 610 in the switching registration screen 600. If it is determined that no execution operation has been performed ("No" in step S4), the determination in step S4 is repeated. Processing is paused until an execution operation is performed.

[0128] Figure 9 This is a diagram of the switching registration screen 600, indicating the status of the selected box 100. When the box 100 is selected as the switching source by operating the selection bar 631 of the box information list 630, the information of the selected box 100 is appended to the bottom row of the box information list 670 of the switching target display unit 650. Figure 9 In the example shown, the box 100 with identification number A23#003 among the two boxes 100 displayed on the switching source display unit 610 is selected, and the information of the box 100 with identification number A23#003 is added to the switching target display unit 650.

[0129] The display can also be changed so that the box 100 selected in the switching source display unit 610 and the box 100 added in the switching target display unit 650 can be easily distinguished from other boxes 100. For example, columns displaying information about the target box 100 can be differentiated by color or highlighted to make them easier to distinguish.

[0130] When the execution operation unit 694 is operated, the registration of the selected box 100 for the switching source agent is deactivated. The selected box 100 is then registered for the switching target agent.

[0131] Return to Figure 6 When it is determined in step S4 that an operation has been performed ("Yes" in step S4), in step S5, the control unit 291 causes the display unit 293 to display a job guidance screen. The job guidance screen guides the user to perform the operation for switching box 100.

[0132] The tasks for switching box 100 may include, for example, cleaning the target box 100, re-pasting the labels pasted on the target box 100, filling the target box 100 with the switching agent, and testing the operation of the target box 100 after filling with the agent. The task guidance screen may contain messages prompting the user to perform the tasks for switching box 100, and may also contain messages indicating the process of the tasks for switching box 100.

[0133] In step S6, the control unit 291 determines whether a completion operation has been performed. The job guidance screen includes a change completion operation unit. Here, the completion operation refers to operating the change completion operation unit after all the jobs for switching box 100 have been completed. When all the jobs for switching box 100 have been completed, the user operates the change completion operation unit to confirm the switching of box 100.

[0134] If it is determined that the operation has not been completed ("No" in step S6), the determination in step S6 is repeated. Processing is paused until the operation is completed. If it is determined that the operation has been completed ("Yes" in step S6), the control unit 291 closes the registration switch screen 600 and the display unit 293 displays other screens. In this way, the series of processes for switching the registration of the medicine box 100 is completed. Figure 6 (The "end").

[0135] <New registration for Box 100>

[0136] Figure 10 This is an example image representing the newly registered screen 700. If in Figure 7 When a drug is selected from the drugs displayed in the switching target list 550 on the drug selection screen 500, and the new registration operation unit 593 is operated, the control unit 291 causes the display unit 293 to display the new registration screen 700. The new registration screen 700 is a screen used for registering the selected drug in the new registration box 100. Figure 10 As shown, the new registration screen 700 includes the drug name 720, the box information list 730, and the operation bar 790.

[0137] The name of the drug selected in the drug selection screen 500 is displayed in drug name 720. Information related to the box 100 registered for the drug displayed in drug name 720 is displayed in box information list 730. Box information list 730 includes box type display field 731, serial ID display field 732, machine number 1 selection field 733, machine number 2 selection field 734, and machine number 3 selection field 735.

[0138] The box type display column 731 displays an identification number indicating the type of box 100 corresponding to the drug shown in the drug name 720. If box 100 is already registered for the drug in the main drug list 300, the box type display column 731 displays an identification number indicating the type of the registered box 100. If box 100 is not registered for the drug in the main drug list 300, the box type display column 731 displays an identification number indicating the type of box 100 registered in the main drug list 300. Figure 5The corresponding data 400 shows the identification number of the type of box 100 that corresponds to the medicine. If the box 100 registered in the main medicine table 300 is different from the box 100 specified in the corresponding data 400, the box 100 registered in the main medicine table 300 will be displayed first in the box type display column 731.

[0139] The serial number of box 100 is displayed in the serial ID display field 732. Checkboxes are displayed in the machine selection fields 733, 734, and 735. For the pharmaceutical packaging device 200 specified as capable of installing box 100 as shown in the serial ID display field 732, a check mark is displayed in at least one of the checkboxes in machine selection fields 733, 734, and 735.

[0140] The operation bar 790 is displayed at the bottom of the new registration screen 700. The operation bar 790 can be operated by clicking the mouse or clicking the screen while the mouse pointer is positioned inside the multiple rectangles included in the operation bar 790. The operation bar 790 includes a close operation unit 792 and a registration operation unit 794.

[0141] By operating the closing operation unit 792, the new registration screen 700 is closed, and the screen displayed on the display unit 293 changes to another screen. By operating the registration operation unit 794, the registration of the drug shown for the drug name 720 is entered into the box 100 of the box information list 730.

[0142] exist Figure 10 The new registration screen 700 shows an example where tablet J is selected as the drug to be registered in the newly imported box 100, and the new imported box 100 is to be registered for tablet J. The name of the selected drug, tablet J, is displayed in drug name 720.

[0143] The box information list 730 displays information about the box 100 registered for tablet J. In this example, the identification number for the type of box 100 registered for tablet J is B52. The identification number B52 is displayed in the box type display column 731 of each row in the box information list 730.

[0144] In this example, for the two boxes 100 with registered identification numbers B52#001 and B52#002 for tablet J, the serial number #001 is displayed in the serial ID display field 732 in the first row of the box information list 730, and a check mark is marked in the machine selection field 733. The serial number #002 is displayed in the serial ID display field 732 in the second row of the box information list 730, and a check mark is marked in the machine selection field 733.

[0145] In the box information list 730, append the required row for the newly registered box 100 below the row displaying information about the already registered boxes 100. Figure 10 In the example shown, the third row of box information list 730 has been added. Box 100 shown in the third row of box information list 730 is the newly registered box 100.

[0146] exist Figure 10 In the third row of the box information list 730, the serial ID display field 732 is blank, and the checkboxes in the selection fields 733 (for machine 1), 734 (for machine 2), and 735 (for machine 3) are not marked with a checkmark. The user enters the serial number in the serial ID display field 732 and marks the checkboxes in at least one of the selection fields 733 (for machine 1), 734 (for machine 2), and 735 (for machine 3). When the user completes the input of information for the newly registered box 100, the registration operation unit 794 is operated. Thus, the new registration of the third box 100 for J tablets is confirmed.

[0147] <Functions and Effects>

[0148] Although there is some overlap with the above description, the characteristic structure, function, and effects of this embodiment are summarized as follows.

[0149] like Figure 7 As shown, when switching the medications contained in the box 100, the display unit 293 displays a list of the medications that are candidates for switching. This list includes the quantity of each medication dispensed from the medication packaging device 200 during the target period, i.e., the usage amount.

[0150] The list of candidates for switching source agents includes the agent usage during the target period, making it easy to select agents with low usage as switching source agents. The list of candidates for switching target agents includes the agent usage during the target period, making it easy to select agents with high usage as switching target agents. By setting agents with low usage as switching source agents and agents with high usage as switching target agents, agent supply can be efficient. This facilitates the registration process for the agent registration box 100, thus aiding in the registration process of box 100.

[0151] like Figure 7 As shown, the target period for counting the medicine dispensed from the medicine packaging device 200 can also be changed. The user can arbitrarily change the target period by specifying the first and last days of the target period. The source medicine and target medicine can be switched based on the usage within any period, and the registration of the medicine box 100 can be switched to efficiently supply medicine.

[0152] like Figure 7As shown, the list of candidate drugs for switching can also contain information on multiple drugs, and can be sorted in ascending or descending order of usage. By sorting the candidate drugs that will become switching sources in ascending order of usage, it is easy to select drugs with lower usage as switching sources. By sorting the candidate drugs that will become switching targets in descending order of usage, it is easy to select drugs with higher usage as switching targets.

[0153] like Figure 7 As shown, the list of candidate drugs for switching can also include the name of the drug and the type of box 100 that can contain the drug. It is easy to confirm whether the box 100 registered for the switching source drug and the box 100 registered for the drug to be selected as the switching target are the same box type and can be switched.

[0154] like Figure 7 As shown, in the list of candidate agents for switching, agents can also be selected based on their name or the type of box 100. By selecting agents that have been discontinued or have been pre-identified as having low usage based on their names, it is easy to select such agents as the switching source agents. Candidate agents as switching targets can be selected based on the type of box 100 registered for the switching source agent, thereby ensuring that the box 100 serving as the switching source and the box 100 serving as the switching target are of the same type, enabling reliable switching.

[0155] like Figure 3 As shown, the drug supply system may also include a storage unit 294. The storage unit 294 may also store... Figure 4 The shown table is the main drug table 300, which registers drug-related information for each drug. For example... Figure 7 As shown, the list of candidates for switching source agents can also include only agents registered in box 100 in the main agent table 300, and exclude agents not registered in box 100 in the main agent table 300. Since there is no box 100 that contains an agent not registered in box 100, such agents are not displayed in the switching source list 540, thereby enabling reliable selection of candidate agents for switching sources and boxes 100 registered for those agents.

[0156] like Figure 7 As shown, the list of candidates for switching target drugs can include both drugs registered in box 100 in the main drug table 300 and drugs not registered in box 100 in the main drug table 300. The target drug is not limited to drugs registered in box 100 in the main drug table 300; drugs that are candidates can be displayed in the list. This expands the range of candidate drugs for switching, allowing for the selection of more suitable drugs as the switching target.

[0157] like Figure 8 As shown, display unit 293 can simultaneously display information related to the source drug being switched and information related to the target drug being switched. A user who wants to switch the registration of the drug box 100 can observe display unit 293 and simultaneously view information related to the source drug being switched and information related to the target drug being switched. The user can select a new box 100 to be registered for the target drug from the boxes 100 registered for the source drug to switch registration.

[0158] like Figure 8 , 9 As shown, in the case of multiple boxes 100 containing switching source agents, it is also possible to select the box 100 to be switched. The user can appropriately determine the number of boxes 100 registered for switching source agents among the boxes 100 registered for switching target agents based on the status of the boxes 100 already registered for switching target agents.

[0159] <Postscript>

[0160] The above description includes the following features.

[0161] (Postscript 1)

[0162] A pharmaceutical supply system includes a pharmaceutical packaging device, the pharmaceutical supply system comprising:

[0163] The drug containment department, which contains drugs; and

[0164] The display unit shows information related to the medicine and its storage compartment.

[0165] When switching between medications contained in the medication storage unit, the display unit shows a list of candidate medications for switching.

[0166] The list includes the quantity of each medicine dispensed from the medicine packaging device during the target period.

[0167] (Postscript 2)

[0168] According to the pharmaceutical supply system described in Appendix 1, wherein,

[0169] The object can be modified during the period.

[0170] (Note 3)

[0171] According to the pharmaceutical supply system described in Appendix 1 or Appendix 2, wherein,

[0172] The list contains information on various medications and can be sorted in ascending or descending order of quantity.

[0173] (Note 4)

[0174] According to any one of Appendix 1 to Appendix 3, the pharmaceutical supply system wherein,

[0175] The list includes the name of the drug and the type of drug containment unit that can contain the drug.

[0176] (Note 5)

[0177] According to any one of Appendix 1 to Appendix 4, the pharmaceutical supply system wherein,

[0178] The list allows you to select candidate drugs for switching based on the drug's name or the type of drug container.

[0179] (Note 6)

[0180] According to any one of Annexes 1 to 5, the pharmaceutical supply system wherein,

[0181] The drug supply system also includes a storage unit that stores a master table of drugs, which records drug-related information for each drug.

[0182] The list of candidates for switching source drugs includes only drugs that are registered in the drug storage compartment in the main drug table, and does not include drugs that are not registered in the drug storage compartment in the main drug table.

[0183] (Note 7)

[0184] According to the pharmaceutical supply system described in Appendix 6, wherein...

[0185] The list of candidates for switching target drugs includes drugs that have been registered in the main drug table and drugs that have not been registered in the main drug table.

[0186] (Postscript 8)

[0187] According to any one of Appendix 1 to Appendix 7, the pharmaceutical supply system wherein,

[0188] The display unit simultaneously displays information related to the switching source drug and information related to the switching target drug.

[0189] (Note 9)

[0190] According to any one of Appendix 1 to Appendix 8, the pharmaceutical supply system wherein,

[0191] In the presence of multiple drug containment units that contain switching source drugs, it is possible to select the drug containment unit to be switched.

[0192] The embodiments disclosed herein should be considered illustrative in all respects and not restrictive. The scope of the invention is not shown by the foregoing description but by the claims, and is intended to include all modifications in the same sense and scope as the claims.

[0193] Explanation of reference numerals in the attached figures

[0194] 1: Prescription input device; 100: Box; 200, 201, 202, 203: Drug packaging device; 290: Control device; 291: Control unit; 292: Operation unit; 293: Display unit; 294: Storage unit; 300: Drug master table; 301~306, 401~406: Drug information; 310, 430: Drug identification information field; 320, 410: Drug name field; 330: Adoption / Discontinuation field; 340: First box identification information field; 3 50: First machine column; 360: Second box identification information column; 370: Second machine column; 400: Corresponding data; 420: Pharmaceutical company name column; 440: Box type column; 500: Drug selection screen; 510: Switch source extraction unit; 511, 521: Box type input unit; 512, 522: Drug name input unit; 513, 523: Pharmaceutical company name input unit; 520: Switch target extraction unit; 530: Target period display; 531: First day of period indicator 532: Final Day Designation Section; 540: Switch Source List; 541, 551, 631: Selection Bar; 542, 552: Drug Name Display Bar; 543, 553: Usage Display Bar; 544, 554, 731: Box Type Display Bar; 545, 556: Adoption / Abortion Display Bar; 550: Switch Target List; 555: Registration Display Bar; 590, 690, 790: Operation Bar; 591: CSV Output Operation Section; 592, 69 2. 792: Close Operation Section; 593: New Registration Operation Section; 594: Switch Operation Section; 600: Switch Registration Screen; 610: Switch Source Display Section; 620, 660, 720: Drug Name; 630, 670, 730: Box Information List; 632, 662, 672: Box Identification Information Display Bar; 650: Switch Target Display Section; 694: Execute Operation Section; 700: New Registration Screen; 732: Serial ID Display Bar; 794: Registration Operation Section.

Claims

1. A pharmaceutical supply system, comprising a pharmaceutical packaging device, wherein the pharmaceutical supply system includes: The pharmaceutical containment department, which contains pharmaceuticals; and The display unit shows information related to the medicine and its storage compartment. in, When switching between medications contained in the medication storage unit, the display unit shows a list of candidate medications for switching. The list contains the quantity of each medicine dispensed from the medicine packaging device during the target period.

2. The drug supply system according to claim 1, wherein, The object can be modified during the period.

3. The drug supply system according to claim 1, wherein, The list contains information on various medications and can be sorted in ascending or descending order of quantity.

4. The drug supply system according to claim 1, wherein, The list includes the name of the drug and the type of drug containment unit that can contain the drug.

5. The drug supply system according to claim 1, wherein, The list allows you to select candidate drugs for switching based on the drug's name or the type of drug container.

6. The drug supply system according to claim 1, wherein, The drug supply system also includes a storage unit that stores a master table of drugs, which records drug-related information for each drug. The list of candidates for switching source drugs includes only drugs that are registered in the drug storage compartment in the main drug table, and does not include drugs that are not registered in the drug storage compartment in the main drug table.

7. The drug supply system according to claim 6, wherein, The list of candidates for switching target drugs includes drugs that have been registered in the main drug table and drugs that have not been registered in the main drug table.

8. The drug supply system according to claim 1, wherein, The display unit simultaneously displays information related to the switching source drug and information related to the switching target drug.

9. The drug supply system according to claim 1, wherein, In the presence of multiple drug containment units that contain switching source drugs, it is possible to select the drug containment unit to be switched.

Images